Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis

Aspirin therapy has shown protective effects against hepatocellular carcinoma (HCC) in preclinical studies. However, it is unclear whether aspirin therapy lowers the risk of HCC in patients with alcoholic cirrhosis. A retrospective analysis of data from 949 consecutive patients with alcoholic cirrho...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Sangdeok, Lee, Sang Hoon, Lee, Minjong, Kim, Ji Hyun, Lee, Wongu, Lee, Hyun Woo, Park, Min Soo, Park, Seungwoo, Kim, Tae Suk, Choi, Dae Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478404/
https://www.ncbi.nlm.nih.gov/pubmed/32118712
http://dx.doi.org/10.1097/MD.0000000000019008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478404/
https://www.ncbi.nlm.nih.gov/pubmed/32118712
http://dx.doi.org/10.1097/MD.0000000000019008

Ejemplares similares